Parvovirus B19 infection and myofasciitis [4]

Clinical Rheumatology

Volumn 23, Issue 2, 2004, Pages 184-185

  Ichinose, Katsuhiro ^a   Migita, Kiyoshi ^a   Sekita, Takaharu ^a   Hamada, Hisayuki ^a   Ezaki, Hironori ^a   Mukoubara, Shigeaki ^a   Eguchi, Katsumi ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; LOXOPROFEN;

ADULT; BED REST; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; ERYTHEMA INFECTIOSUM; FASCIITIS; GASTROCNEMIUS MUSCLE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LEG MUSCLE; LETTER; MALE; MUSCLE WEAKNESS; MYALGIA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SOLEUS MUSCLE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FASCIITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MYOSITIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PHENYLPROPIONATES; TREATMENT OUTCOME;

EID: 2342427799     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0837-8     Document Type: Letter

References (7)

1. Thurn J (1998) Human parvovirus B19: historical and clinical review. Rev Infect Dis 10:1005-1011
2. Kerr JR (2000) Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 59:672-683
3. Bousvaros A, Sundel R, Thorne GM et al. (1998) Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol 26:365-369
4. Kalish RA, Knopf AN, Gary GW, Canoso JJ (1992) Lupus-like presentation of human parvovirus B19 infection. J Rheumatol 19:169-171
5. Finkel TH, Torok TJ, Ferguson PJ et al. (1994) Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343:1255-1258
6. Ozawa K, Ayub J, Hao YS, Kurtzman G, Shimada T, Young N (1987) Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 61:2395-2406
7. Moffatt S, Tanaka N, Tada K et al. (1996) A cytotoxic non-structural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 70:8485-8491